tRF/miR-1280 binds to and inhibits the expression of the downstream target gene of the Notch pathway, JAG2, which results in the loss of stemness in cancer cells and a reduction in the number of cancer cells with EMT phenotypes, thus inhibiting the growth and metastasis of CRC (Figure 4I) (8). Here, JAG2 is linked to cancer.